{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:55:22Z","timestamp":1793660122261,"version":"4.5.1"},"reference-count":107,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>Community-acquired pneumonia (CAP) is a major cause of morbidity and mortality in children and adults. The burden is especially high among older adults and those with comorbidities. It is also the leading cause of hospital admissions during the annual Islamic pilgrimage (Hajj). CAP is a heterogeneous illness, varying in both etiology and clinical course across different patients. The Saudi Thoracic Society (STS) has developed evidence-based guidelines for the diagnosis, management, and prevention of CAP in both adult and pediatric populations in Saudi Arabia. This is the first guideline of its kind to combine both patient populations in one guideline. Although data on various aspects of CAP \u2013 especially within Saudi Arabia \u2013 remain limited, the task force based its recommendations on the best available evidence and a structured voting process to answer preset clinical questions. Main highlights from the guidelines include that routine complete blood count may assist in guiding management, particularly in severe disease, while acute-phase reactants (C-reactive protein, procalcitonin) are not recommended at initial diagnosis but may be useful if patients fail to improve. Blood cultures and sputum Gram stain\/culture should not be routinely performed, except in severe or deteriorating cases or in hospitalized patients. Respiratory testing for viral pathogens and atypical bacteria is suggested when clinically indicated, especially during outbreaks or in high-risk groups. Chest radiography is recommended in adults and hospitalized children. Short-course antibiotic therapy is favored for improving patients, with early transition from intravenous to oral therapy when hospitalized. Macrolides are preferred over fluoroquinolones in outpatients, while combination beta-lactam plus macrolide therapy is recommended for inpatients. Preventive measures, particularly vaccination, are strongly endorsed. Special considerations apply to elderly, pregnant, chronic obstructive pulmonary disease, and immunocompromised patients. Corticosteroids may benefit select severe cases but are not recommended routinely. These guidelines are intended primarily for general practitioners, emergency physicians, pediatricians, and internal medicine specialists. To enhance accessibility and implementation, STS has simplified the guidelines and provided an executive summary of the key recommendations.<\/jats:p>","DOI":"10.4103\/atm.atm_293_25","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:00:18Z","timestamp":1761033618000},"page":"195-212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The Saudi Thoracic Society evidence-based guidelines for the diagnosis and management of community-acquired pneumonia in children and adults"],"prefix":"10.4103","volume":"20","author":[{"given":"Sami Mohammed A.","family":"Alyami","sequence":"first","affiliation":[{"name":"Department of Medicine, Pulmonary Division, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia"},{"name":"College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alzomor","sequence":"additional","affiliation":[{"name":"Department of Pediatric Infectious Diseases, Children\u2019s Hospital, King Saud Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imad Salah","family":"Hassan","sequence":"additional","affiliation":[{"name":"Department of Medical Protocols, Internal Medicine Section, King Abdulaziz Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"AlShamrani","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"},{"name":"Director of Infection Prevention and Control Program, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrazaq S.","family":"Al-Jazairi","sequence":"additional","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohmmed","family":"Algamdi","sequence":"additional","affiliation":[{"name":"Department of Medicine, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezar","family":"Bahabri","sequence":"additional","affiliation":[{"name":"Chairman, Saudi Society of Microbiology and Infectious Diseases, King Fahd Hospital of the University, Al-Khobar, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turki S.","family":"Alahmadi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Rabigh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabiha A.","family":"Tashkandi","sequence":"additional","affiliation":[{"name":"Department of Nursing Services, King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer S.","family":"Alkhairallah","sequence":"additional","affiliation":[{"name":"Department of Quality and Patient Safety, Ministry of National Guard Health Affairs \u2013 Central Region, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Aljindan","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Memish","sequence":"additional","affiliation":[{"name":"Research and Innovation Center, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esam H.","family":"Alhamad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,20]]},"reference":[{"key":"R1-20260420","article-title":"Clinical Overview: Community-Acquired Pneumonia in Adults","year":"2022","journal-title":"Clinical Key"},{"key":"R2-20260420","article-title":"Clinical Overview: Community-Acquired Pneumonia in Children (Older Than 3 Months)","year":"2022","journal-title":"Clinical Key"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1093\/cid\/cir531","article-title":"The management of community-acquired pneumonia in infants and children older than 3 months of age: Clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America","volume":"53","author":"Bradley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R4-20260420","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4103\/ajop.ajop_21_21","article-title":"Bacterial pathogens in sputum of children with community-acquired pneumonia, unexpected results: A single hospital-based study","volume":"34","author":"Zaki","year":"2021","journal-title":"Alex J Pediatr"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jiph.2021.05.008","article-title":"Clinical characteristics and outcomes of community-acquired pneumonia in Western Saudi Arabia: A four-year retrospective analysis of medical records","volume":"14","author":"Farahat","year":"2021","journal-title":"J Infect Public Health"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijid.2014.06.003","article-title":"Etiology of severe community-acquired pneumonia during the 2013 Hajj-part of the MERS-CoV surveillance program","volume":"25","author":"Memish","year":"2014","journal-title":"Int J Infect Dis"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"R10-20260420","doi-asserted-by":"crossref","first-page":"e577","DOI":"10.1016\/S2589-7500(21)00115-1","article-title":"Anosmia, ageusia, and other COVID-19-like symptoms in association with a positive SARS-CoV-2 test, across six national digital surveillance platforms: An observational study","volume":"3","author":"Sudre","year":"2021","journal-title":"Lancet Digit Health"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/adc.82.1.41","article-title":"Diagnostic value of tachypnoea in pneumonia defined radiologically","volume":"82","author":"Palafox","year":"2000","journal-title":"Arch Dis Child"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1097\/INF.0000000000003008","article-title":"Pneumonia in hospitalized children during SARS-CoV-2 pandemic. Is it all COVID-19? Comparison between COVID and Non-COVID pneumonia","volume":"40","author":"Jimenez-Garc\u00eda","year":"2021","journal-title":"Pediatr Infect Dis J"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/INF.0000000000002660","article-title":"Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children","volume":"39","author":"Zimmermann","year":"2020","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 2","key":"R14-20260420","first-page":"i1","article-title":"British Thoracic Society guidelines for the management of community acquired pneumonia in children: Update 2011","volume":"66","author":"Harris","year":"2011","journal-title":"Thora\u00d7"},{"issue":"Suppl 2","key":"R15-20260420","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"43","DOI":"10.12703\/P5-43","article-title":"Major advances in managing community-acquired pneumonia","volume":"5","author":"Asrar Khan","year":"2013","journal-title":"F1000Prime Rep"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3855\/jidc.9585","article-title":"Performance of CURB-65 in predicting mortality of patients with community-acquired pneumonia in Saudi Arabia","volume":"11","author":"Al-Tawfiq","year":"2017","journal-title":"J Infect Dev Ctries"},{"issue":"2","key":"R18-20260420","article-title":"Comparison between CURB-65, PSI, and SIPF scores as predictors of ICU admission and mortality in community-acquired pneumonia","volume":"3","author":"Eldaboosy","year":"2015","journal-title":"Egypt J Crit Care Med"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"e13667","DOI":"10.1111\/ijcp.13667","article-title":"Aetiology and antimicrobial susceptibility pattern of bacterial isolates in community acquired pneumonia patients at Asir region, Saudi Arabia","volume":"75","author":"Batool","year":"2021","journal-title":"Int J Clin Pract"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"69","DOI":"10.4103\/jgid.jgid_84_18","article-title":"Empiric antibiotic therapy in the treatment of community-acquired pneumonia in a general hospital in Saudi Arabia","volume":"11","author":"Al-Tawfiq","year":"2019","journal-title":"J Glob Infect Dis"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/IDR.S97416","article-title":"Burden of methicillin-resistant Staphylococcus aureus pneumonia among hospitalized patients in Lebanon and Saudi Arabia","volume":"10","author":"Althaqafi","year":"2017","journal-title":"Infect Drug Resist"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.tmaid.2017.10.004","article-title":"Influenza is more common than Middle East respiratory syndrome coronavirus (MERS-CoV) among hospitalized adult Saudi patients","volume":"20","author":"Al-Tawfiq","year":"2017","journal-title":"Travel Med Infect Dis"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijid.2018.02.008","article-title":"Proportion of adult community-acquired pneumonia cases attributable to Streptococcus pneumoniae among Hajj pilgrims in 2016","volume":"69","author":"AlBarrak","year":"2018","journal-title":"Int J Infect Dis"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jiph.2016.04.016","article-title":"Mass gathering medicine (Hajj Pilgrimage in Saudi Arabia): The clinical pattern of pneumonia among pilgrims during Hajj","volume":"10","author":"Shirah","year":"2017","journal-title":"J Infect Public Health"},{"key":"R25-20260420","first-page":"122","article-title":"Epidemiology and antimicrobial resistance of community acquired pneumonia in children","volume":"4","author":"Mansour","year":"2017","journal-title":"J Health Res Rev"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4167\/jbv.2010.40.4.159","article-title":"Incidence and antimicrobial susceptibility of Mycoplasma pneumoniae in Saudi Arabia","volume":"40","author":"Marie","year":"2010","journal-title":"J Bacteriol Virol"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE evidence to decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE\u2013ADOLOPMENT","volume":"81","author":"Sch\u00fcnemann","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"R28-20260420","article-title":"GRADE Handbook","author":"Sch\u00fcnemann","year":"2013","journal-title":"Handbook for Grading the Quality of Evidence and the Strength of Recommendations Using the GRADE Approach"},{"key":"R29-20260420","doi-asserted-by":"crossref","first-page":"E123","DOI":"10.1503\/cmaj.131237","article-title":"Guidelines 2.0: Systematic development of a comprehensive checklist for a successful guideline enterprise","volume":"186","author":"Sch\u00fcnemann","year":"2014","journal-title":"CMAJ"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"548","DOI":"10.7326\/M14-1885","article-title":"Guidelines international network: Principles for disclosure of interests and management of conflicts in guidelines","volume":"163","author":"Sch\u00fcnemann","year":"2015","journal-title":"Ann Intern Med"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: The significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"R32-20260420","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/jep.12927","article-title":"Adapting evidence-based clinical practice guidelines at university teaching hospitals: A model for the Eastern Mediterranean Region","volume":"25","author":"Amer","year":"2019","journal-title":"J Eval Clin Pract"},{"key":"R33-20260420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/healthcare4030036","article-title":"Barriers and strategies in guideline implementation-a scoping review","volume":"4","author":"Fischer","year":"2016","journal-title":"Healthcare (Basel)"},{"key":"R34-20260420","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/ijpp.12654","article-title":"A systematic review using the theoretical domains framework to identify barriers and facilitators to the adoption of prescribing guidelines","volume":"29","author":"Paksaite","year":"2021","journal-title":"Int J Pharm Pract"},{"key":"R35-20260420","doi-asserted-by":"crossref","first-page":"e1002207","DOI":"10.1371\/journal.pmed.1002207","article-title":"Reporting items for updated clinical guidelines: Checklist for the reporting of updated guidelines (checkup)","volume":"14","author":"Vernooij","year":"2017","journal-title":"PLoS Med"},{"key":"R36-20260420","doi-asserted-by":"crossref","first-page":"ofab169","DOI":"10.1093\/ofid\/ofab169","article-title":"Lymphopenia is associated with poor outcomes of patients with community-acquired pneumonia and sepsis","volume":"8","author":"Cilloniz","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"R37-20260420","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/00006454-200007000-00003","article-title":"Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children","volume":"19","author":"Toikka","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R38-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcla.20333","article-title":"Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children?","volume":"24","author":"Khan","year":"2010","journal-title":"J Clin Lab Anal"},{"key":"R39-20260420","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/01.inf.0000095197.72976.4f","article-title":"Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection","volume":"22","author":"Prat","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R40-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jemermed.2006.12.034","article-title":"Selective use of blood cultures in emergency department pneumonia patients","volume":"33","author":"Benenson","year":"2007","journal-title":"J Emerg Med"},{"key":"R41-20260420","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/jama.1997.03550230056037","article-title":"Quality of care, process, and outcomes in elderly patients with pneumonia","volume":"278","author":"Meehan","year":"1997","journal-title":"JAMA"},{"key":"R42-20260420","doi-asserted-by":"crossref","first-page":"e20171013","DOI":"10.1542\/peds.2017-1013","article-title":"Utility of blood culture among children hospitalized with community-acquired pneumonia","volume":"140","author":"Neuman","year":"2017","journal-title":"Pediatrics"},{"key":"R43-20260420","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1378\/chest.108.4.932","article-title":"Clinical utility of blood cultures in adult patients with community-acquired pneumonia without defined underlying risks","volume":"108","author":"Chalasani","year":"1995","journal-title":"Chest"},{"key":"R44-20260420","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jpeds.2015.09.025","article-title":"A cost-effectiveness analysis of obtaining blood cultures in children hospitalized for community-acquired pneumonia","volume":"167","author":"Andrews","year":"2015","journal-title":"J Pediatr"},{"key":"R45-20260420","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2147\/CEOR.S224619","article-title":"Cost-effectiveness of culture-based versus empirical antibiotic treatment for hospitalized adults with community-acquired pneumonia in Indonesia: A real-world patient-database study","volume":"11","author":"Purba","year":"2019","journal-title":"Clinicoecon Outcomes Res"},{"key":"R46-20260420","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/intqhc\/mzt078","article-title":"Impact of guideline-concordant microbiological testing on outcomes of pneumonia","volume":"26","author":"Uematsu","year":"2014","journal-title":"Int J Qual Health Care"},{"key":"R47-20260420","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s11739-016-1445-3","article-title":"Adherence to guidelines for hospitalized community-acquired pneumonia over time and its impact on health outcomes and mortality","volume":"11","author":"Costantini","year":"2016","journal-title":"Intern Emerg Med"},{"key":"R48-20260420","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S1806-37132008000300005","article-title":"Sputum examination in the clinical management of community-acquired pneumonia","volume":"34","author":"Signori","year":"2008","journal-title":"J Bras Pneumol"},{"key":"R49-20260420","doi-asserted-by":"crossref","first-page":"1038.e1","DOI":"10.1016\/j.cmi.2018.11.031","article-title":"The potential economic value of sputum culture use in patients with community-acquired pneumonia and healthcare-associated pneumonia","volume":"25","author":"Asti","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"R50-20260420","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/adc.88.6.525","article-title":"Effect of a rapid influenza diagnosis","volume":"88","author":"Esposito","year":"2003","journal-title":"Arch Dis Child"},{"key":"R51-20260420","doi-asserted-by":"crossref","first-page":"e0182091","DOI":"10.1371\/journal.pone.0182091","article-title":"Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting","volume":"12","author":"You","year":"2017","journal-title":"PLoS One"},{"key":"R52-20260420","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/00005650-198307000-00001","article-title":"The effect of chest radiographs on the management and clinical course of patients with acute cough","volume":"21","author":"Bushyhead","year":"1983","journal-title":"Med Care"},{"key":"R53-20260420","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0140-6736(97)07013-X","article-title":"Randomised controlled trial of clinical outcome after chest radiograph in ambulatory acute lower-respiratory infection in children","volume":"351","author":"Swingler","year":"1998","journal-title":"Lancet"},{"key":"R54-20260420","doi-asserted-by":"crossref","first-page":"e765","DOI":"10.3399\/bjgp18X699545","article-title":"Diagnosis and treatment of community-acquired pneumonia in patients with acute cough: A quantitative study of decision thresholds in primary care","volume":"68","author":"Ebell","year":"2018","journal-title":"Br J Gen Pract"},{"key":"R55-20260420","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/archinte.161.17.2099","article-title":"Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals","volume":"161","author":"Dedier","year":"2001","journal-title":"Arch Intern Med"},{"key":"R56-20260420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1086\/509331","article-title":"Routine use of the pneumonia severity index for guiding the site-of-treatment decision of patients with pneumonia in the emergency department: A multicenter, prospective, observational, controlled cohort study","volume":"44","author":"Renaud","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R57-20260420","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.annemergmed.2015.02.003","article-title":"Impact of an electronic clinical decision support tool for emergency department patients with pneumonia","volume":"66","author":"Dean","year":"2015","journal-title":"Ann Emerg Med"},{"key":"R58-20260420","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.arbres.2012.12.008","article-title":"Improved management of community-acquired pneumonia in the emergency department","volume":"49","author":"Juli\u00e1n-Jim\u00e9nez","year":"2013","journal-title":"Arch Bronconeumol"},{"key":"R59-20260420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jemermed.2010.04.018","article-title":"The effects of incorporating a pneumonia severity index into the admission protocol for community-acquired pneumonia","volume":"42","author":"Jo","year":"2012","journal-title":"J Emerg Med"},{"key":"R60-20260420","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.4103\/njcp.njcp_433_18","article-title":"Prognostic utility of CURB-65 and E-CURB-65 scoring systems in healthcare associated pneumonia patients: Short- and long-term mortality","volume":"24","author":"Kurt","year":"2021","journal-title":"Niger J Clin Pract"},{"key":"R61-20260420","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S2213-2600(16)30223-5","article-title":"Development and internal validation of a clinical rule to improve antibiotic use in children presenting to primary care with acute respiratory tract infection and cough: A prognostic cohort study","volume":"4","author":"Hay","year":"2016","journal-title":"Lancet Respir Med"},{"key":"R62-20260420","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: Randomised, double blind study","volume":"332","author":"el Moussaoui","year":"2006","journal-title":"BMJ"},{"key":"R63-20260420","doi-asserted-by":"crossref","first-page":"e12959","DOI":"10.1111\/ijcp.12959","article-title":"Enablers and barriers to the use of antibiotic guidelines in the assessment and treatment of community-acquired pneumonia-a qualitative study of clinicians\u2019 perspectives","volume":"71","author":"Sedrak","year":"2017","journal-title":"Int J Clin Pract"},{"key":"R64-20260420","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/archinte.158.12.1350","article-title":"Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: An interventional trial","volume":"158","author":"Atlas","year":"1998","journal-title":"Arch Intern Med"},{"key":"R65-20260420","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotic treatment in community-acquired pneumonia: A multicenter randomized clinical trial","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med"},{"key":"R66-20260420","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1183\/09031936.04.00076704","article-title":"A population-based study of the costs of care for community-acquired pneumonia","volume":"23","author":"Bartolom\u00e9","year":"2004","journal-title":"Eur Respir J"},{"key":"R67-20260420","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jac\/dkh356","article-title":"Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia","volume":"54","author":"Tellier","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R68-20260420","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(20)31550-6","article-title":"Complicated pneumonia in children","volume":"396","author":"de Benedictis","year":"2020","journal-title":"Lancet"},{"key":"R69-20260420","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1542\/peds.112.2.363","article-title":"Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: Results of a randomized, prospective, controlled trial","volume":"112","author":"Bonner","year":"2003","journal-title":"Pediatrics"},{"key":"R70-20260420","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1197\/j.aem.2006.07.026","article-title":"Effect of point-of-care influenza testing on management of febrile children","volume":"13","author":"Iyer","year":"2006","journal-title":"Acad Emerg Med"},{"key":"R71-20260420","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.pec.0000202454.19237.b0","article-title":"Impact of rapid influenza testing at triage on management of febrile infants and young children","volume":"22","author":"Abanses","year":"2006","journal-title":"Pediatr Emerg Care"},{"key":"R72-20260420","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/523584","article-title":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada","volume":"45","author":"McGeer","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R73-20260420","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/cid\/cis636","article-title":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1) pdm09","volume":"55","author":"Louie","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R74-20260420","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jinf.2016.07.001","article-title":"De-escalation versus continuation of empirical antimicrobial therapy in community-acquired pneumonia","volume":"73","author":"Yamana","year":"2016","journal-title":"J Infect"},{"key":"R75-20260420","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ejim.2015.04.002","article-title":"Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia","volume":"26","author":"Rossio","year":"2015","journal-title":"Eur J Intern Med"},{"key":"R76-20260420","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4103\/atm.atm_202_24","article-title":"The Saudi thoracic society guidelines for vaccinations in adult patients with chronic respiratory diseases","volume":"20","author":"Al Ghobain","year":"2025","journal-title":"Ann Thorac Med"},{"key":"R77-20260420","doi-asserted-by":"crossref","first-page":"1783048","DOI":"10.1080\/19932820.2020.1783048","article-title":"Trends and health burden of hospitalized acute respiratory infections and impact of haemophilus influenza immunization in a Tunisian university hospital: A twelve-year study","volume":"15","author":"Ben Fredj","year":"2020","journal-title":"Libyan J Med"},{"key":"R78-20260420","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1016\/j.vaccine.2021.06.075","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study","volume":"39","author":"Zhang","year":"2021","journal-title":"Vaccine"},{"key":"R79-20260420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1183\/09031936.00133510","article-title":"Influenza vaccination is associated with reduced severity of community-acquired pneumonia","volume":"38","author":"Tessmer","year":"2011","journal-title":"Eur Respir J"},{"key":"R80-20260420","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.vaccine.2016.01.038","article-title":"The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia","volume":"34","author":"Sanz-Herrero","year":"2016","journal-title":"Vaccine"},{"key":"R81-20260420","doi-asserted-by":"crossref","first-page":"e0147931","DOI":"10.1371\/journal.pone.0147931","article-title":"Factors associated with influenza vaccination of hospitalized elderly patients in Spain","volume":"11","author":"Dom\u00ednguez","year":"2016","journal-title":"PLoS One"},{"key":"R82-20260420","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.vaccine.2017.01.032","article-title":"Exploratory efficacy endpoints in the community-acquired pneumonia immunization trial in adults (CAPiTA)","volume":"35","author":"Webber","year":"2017","journal-title":"Vaccine"},{"key":"R83-20260420","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jpids\/piw089","article-title":"Rapid decrease in rates of hospitalization resulting from invasive pneumococcal disease and community-acquired pneumonia in children aged<60 months after 13-valent pneumococcal conjugate vaccine introduction in Argentina","volume":"7","author":"L\u00f3pez","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R84-20260420","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/ciu006","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children","volume":"58","author":"Angoulvant","year":"2014","journal-title":"Clin Infect Dis"},{"key":"R85-20260420","doi-asserted-by":"crossref","first-page":"e167","DOI":"10.26633\/RPSP.2018.167","article-title":"Community acquired pneumonia incidence among children less than 5 years of age in Concordia, Argentina: Vaccination impact","volume":"42","author":"Ruvinsky","year":"2018","journal-title":"Rev Panam Salud Publica"},{"key":"R86-20260420","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/S0149-2918(02)80084-4","article-title":"A comparison of cefditoren pivoxil and amoxicillin\/clavulanate in the treatment of community-acquired pneumonia: A multicenter, prospective, randomized, investigator-blinded, parallel-group study","volume":"24","author":"Fogarty","year":"2002","journal-title":"Clin Ther"},{"key":"R87-20260420","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/jac\/37.3.555","article-title":"Comparison of oral cefuroxime axetil and oral amoxycillin\/clavulanate in the treatment of community-acquired pneumonia","volume":"37","author":"Higuera","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"R88-20260420","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1183\/09031936.95.08030398","article-title":"Efficacy of a three day course of azithromycin in moderately severe community-acquired pneumonia","volume":"8","author":"Rizzato","year":"1995","journal-title":"Eur Respir J"},{"key":"R89-20260420","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3109\/00365549409008639","article-title":"Three-day azithromycin compared with ten-day roxithromycin treatment of atypical pneumonia","volume":"26","author":"Sch\u00f6nwald","year":"1994","journal-title":"Scand J Infect Dis"},{"key":"R90-20260420","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1128\/AAC.49.10.4035-4041.2005","article-title":"Novel, single-dose microsphere formulation of azithromycin versus 7-day levofloxacin therapy for treatment of mild to moderate community-acquired pneumonia in adults","volume":"49","author":"D\u2019Ignazio","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R91-20260420","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0149-2918(02)85148-7","article-title":"A controlled, double-blind, multicenter study comparing clarithromycin extended-release tablets and levofloxacin tablets in the treatment of community-acquired pneumonia","volume":"24","author":"Gotfried","year":"2002","journal-title":"Clin Ther"},{"key":"R92-20260420","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1001\/jama.283.6.749","article-title":"A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL study investigators. Community-acquired pneumonia intervention trial assessing levofloxacin","volume":"283","author":"Marrie","year":"2000","journal-title":"JAMA"},{"key":"R93-20260420","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/S0149-2918(02)80034-0","article-title":"A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia","volume":"24","author":"Frank","year":"2002","journal-title":"Clin Ther"},{"key":"R94-20260420","first-page":"321","article-title":"An open-label, randomized comparison of levofloxacin and amoxicillin\/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia","volume":"30","author":"Lin","year":"2007","journal-title":"Chang Gung Med J"},{"issue":"Suppl B","key":"R95-20260420","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/jac\/41.suppl_2.75","article-title":"Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia","volume":"41","author":"Salvarezza","year":"1998","journal-title":"J Antimicrob Chemother"},{"key":"R96-20260420","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00044011-200323080-00001","article-title":"Comparison of clarithromycin and amoxicillin\/clavulanic acid for community-acquired pneumonia in an era of drug-resistant Streptococcus pneumoniae","volume":"23","author":"Bonvehi","year":"2003","journal-title":"Clin Drug Investig"},{"key":"R97-20260420","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s11596-006-0411-0","article-title":"Efficacy and safety of intravenous moxifloxacin versus cefoperazone with azithromycin in the treatment of community acquired pneumonia","volume":"26","author":"Xu","year":"2006","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"R98-20260420","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF03261911","article-title":"High-dose levofloxacin in community-acquired pneumonia: A randomized, open-label study","volume":"32","author":"Lee","year":"2012","journal-title":"Clin Drug Investig"},{"key":"R99-20260420","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa1406330","article-title":"Antibiotic treatment strategies for community-acquired pneumonia in adults","volume":"372","author":"Postma","year":"2015","journal-title":"N Engl J Med"},{"key":"R100-20260420","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-Lactam monotherapy versus \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: A randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"R101-20260420","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1001\/jama.2010.479","article-title":"Pandemic 2009 influenza A (H1N1) virus illness among pregnant women in the United States","volume":"303","author":"Siston","year":"2010","journal-title":"JAMA"},{"key":"R102-20260420","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.2147\/COPD.S347948","article-title":"Eosinopenia predicting long-term mortality in hospitalized acute exacerbation of COPD patients with community-acquired pneumonia-a retrospective analysis","volume":"16","author":"Mao","year":"2021","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"R103-20260420","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4046\/trd.2019.0073","article-title":"Reasons and risk factors for readmission following hospitalization for community-acquired pneumonia in South Korea","volume":"83","author":"Jang","year":"2020","journal-title":"Tuberc Respir Dis (Seoul)"},{"key":"R104-20260420","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1183\/09031936.00128107","article-title":"Early mortality in patients with community-acquired pneumonia: Causes and risk factors","volume":"32","author":"Garcia-Vidal","year":"2008","journal-title":"Eur Respir J"},{"key":"R105-20260420","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-2600(24)00405-3","article-title":"Predicting benefit from adjuvant therapy with corticosteroids in community-acquired pneumonia: A data-driven analysis of randomised trials","volume":"13","author":"Smit","year":"2025","journal-title":"Lancet Respir Med"},{"key":"R106-20260420","doi-asserted-by":"crossref","first-page":"154507","DOI":"10.1016\/j.jcrc.2023.154507","article-title":"Efficacy and safety of corticosteroids for the treatment of community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials","volume":"80","author":"Cheema","year":"2024","journal-title":"J Crit Care"},{"key":"R107-20260420","doi-asserted-by":"crossref","first-page":"240081","DOI":"10.1183\/20734735.0081-2024","article-title":"Steroids in severe community-acquired pneumonia","volume":"20","author":"Ananth","year":"2024","journal-title":"Breathe (Sheff)"}],"container-title":["Annals of Thoracic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.atm_293_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:20:12Z","timestamp":1787836812000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/atm.atm_293_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":107,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/atm.atm_293_25","relation":{},"ISSN":["1817-1737","1998-3557"],"issn-type":[{"value":"1817-1737","type":"print"},{"value":"1998-3557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-08-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}